Item 2.02 Results of Operations and Financial Condition.

On August 6, 2020, Antares Pharma, Inc. (the "Company") issued a press release announcing its operating and financial results for the quarter ended June 30, 2020. The full text of such press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.

The information furnished pursuant to Item 2.02 of this Current Report, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific references in such filing.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.



Exhibit
  No.     Description

99.1        Press Release issued by Antares Pharma, Inc., dated August 6, 2020

104       Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses